hero video poster

Press & Resources

14 January 2025

Alleviant Medical Secures $90 Million Financing to Expand Interventional Heart Failure Pivotal Trial Program

Novel Heart Failure Technology from Alleviant Medical Gains FDA Approval for New Pivotal Trial and Breakthrough Designation for Significant Patient Population

ACC 2024 Insights: Interatrial Shunting in Heart Failure: Where Do We Stand? (May 2, 2024)

Dr. Jim Udelson, Dr. Sanjiv Shah, and Dr. C. Michael Gibson Discuss: The take home lessons from the RELIEVE HF study and the path forward (April 25, 2024)

Corvia Medical. (2024, April 11). ACC24 RELIEVE-HF Deep Dive - Sanjiv Shah. YouTube

No-Implant Interatrial Shunt for HFpEF: Six-Month Outcomes From Multicenter Pilot Feasibility Studies

26 January 2023

Alleviant Medical Closes $75M in Financing; Receives FDA IDE Approval for Pivotal Clinical Trial

Feasibility of a No-Implant Approach to Interatrial Shunts: Preclinical and Early Clinical Studies

No-implant interatrial shunt device to treat heart failure patients reveals promising multi-center clinical data

Alleviant Medical: Alleviant System Procedure Animation (youtube.com)

Alleviant Medical Announces Presentation of Clinical Data at American College of Cardiology and EuroPCR Conferences

25 January 2021

Alleviant Medical Receives Breakthrough Device Designation From FDA for Transcatheter Technology

sdy aSD

asdjbnasdjb

asdjbnasdjb

asdb`da,dbasbda,sdb

34234234

adflaljdhasldjhas

adflaljdhasldjhas

sandjkasd kjzb dkahb djakbsd jasbd ajksd

CAUTION - Investigational device - Not for sale. Limited by Federal (or United States) law to investigational use. Exclusively for clinical investigation and to be used by qualified investigators only.